Correction to: Scientific Reports 10.1038/s41598-021-88050-9, published online 20 April 2021
The original version of this Article contained errors in Tables 1, 2 and 3 where previous versions of the tables were published.
The original Tables 1, 2 and 3 and accompanying legends appear below.
Table 1.
Baseline characteristics of study population.
| Variables | Raynaud scan | p value | |
|---|---|---|---|
| Preserved (n = 34) | Impaired (n = 35) | ||
| Demographics | |||
| Age (years) | 69.3 ± 10.2 | 63.0 ± 12.1 | 0.022 |
| Male (%) | 23 (67.6) | 26 (74.3) | 0.543 |
| Conventional risk factors (%) | |||
| Hypertension | 22 (64.7) | 17 (48.6) | 0.176 |
| Diabetes mellitus | 14 (41.2) | 11 (31.4) | 0.400 |
| Dyslipidemia | 10 (29.4) | 9 (25.7) | 0.731 |
| Atrial fibrillation | 2 (5.9) | 6 (17.1) | 0.259 |
| Smoking | 6 (17.6) | 15 (42.9) | 0.023 |
| Previous stroke | 7 (20.6) | 5 (14.3) | 0.490 |
| Neurological Severity | |||
| Proximal muscle strength | 4 [4–5] | 4 [3.25–4] | 0.390 |
| Distal muscle strength | 4 [3.75–5] | 4 [3.25–4.75] | 0.924 |
| NIHSS at admission | 4.5 [2–6] | 4 [2–6.75] | 0.325 |
| NIHSS at discharge | 2 [0–3] | 2 [1–3.75] | 0.308 |
| Associated symptoms (%) | |||
| Affected limb edema | 21 (61.8) | 32 (91.4) | 0.004 |
| Abnormal sensation | 9 (26.5) | 8 (22.9) | 0.728 |
NIHSS National Institutes of Health Stroke Scale.
Table 2.
Diagnostic features of study population.
| Variables | Raynaud scan | p value | |
|---|---|---|---|
| Preserved (n = 34) | Impaired (n = 35) | ||
| Stenosis of artery (%) | |||
| Intracranial | 12 (35.3) | 15 (42.9) | 0.520 |
| Extracranial | 6 (17.6) | 8 (22.9) | 0.591 |
| Distribution of lesion (%) | |||
| Anterior circulation | 20 (58.8) | 30 (85.7) | 0.012 |
| Cortex | 5 (14.7) | 12 (34.3) | 0.059 |
| Electrophysiologic test (%) b | |||
| QSART | 22 (91.7) | 17 (81.0) | 0.396 |
| SSR | 4 (16.7) | 3 (14.3) | 1.000 |
| Laboratory findings | |||
| White blood cell (103/µl) | 7.75 ± 2.28 | 8.25 ± 2.78 | 0.424 |
| Hemoglobin (1003/µl) | 14.08 ± 1.77 | 14.09 ± 1.96 | 0.979 |
| Platelet (103/µl) | 248.65 ± 58.44 | 253.26 ± 73.88 | 0.775 |
| ESR (mm/hr) | 14.38 ± 10.79 | 16.63 ± 13.82 | 0.455 |
| hs-CRP (mg/L) | 5.22 ± 11.70 | 3.97 ± 9.95 | 0.631 |
| Total cholesterol (mg/dl)a | 169.5 ± 34.8 | 171.2 ± 32.7 | 0.833 |
| Triglycerides (mg/dl) | 159.8 ± 103.0 | 161.3 ± 87.0 | 0.948 |
| HDL (mg/dl) | 40.6 ± 8.6 | 43.3 ± 13.1 | 0.326 |
| LDL (mg/dl) | 109.0 ± 36.5 | 106.6 ± 32.1 | 0.721 |
| HbA1c (%) | 6.5 ± 1.4 | 6.5 ± 1.6 | 0.833 |
QSART Quantitative sudomotor axon reflex test, SSR sympathetic skin response, ESR erythrocyte sedimentation rate, hs-CRP high sensitivity C-reactive protein, HDL high density lipoprotein, LDL low density lipoprotein, HbA1c hemoglobin A1c.
aLipid profile (Preserved 33, Impaired 34).
bPreserved 24, Impaired 22.
Table 3.
Logistic regression analysis according to Raynaud scan results.
| Variables | Univariate analysis | Multivariate analysisa | ||
|---|---|---|---|---|
| Crude OR (95% CI) | p value | Adjusted OR (95% CI) | p value | |
| Demographics | ||||
| Age (years) | 0.951 (0.909–0.994) | 0.026 | ||
| Sex | 0.724 (0.255–2.057) | 0.544 | ||
| Associated symptoms | ||||
| Affected limb edema | 6.603 (1.677–26.005) | 0.007 | 15.364 (2.774–85.087) | 0.002 |
| Abnormal sensation | 0.823 (0.275–2.465) | 0.728 | ||
| Conventional risk factors (%) | ||||
| Hypertension | 0.515 (0.196–1.354) | 0.179 | ||
| Diabetes mellitus | 0.655 (0.244–1.758) | 0.401 | ||
| Dyslipidemia | 0.831 (0.288–2.392) | 0.731 | ||
| Atrial fibrillation | 3.310 (0.619–17.715) | 0.162 | ||
| Smoking | 3.500 (1.157–10.589) | 0.027 | ||
| Previous stroke | 0.643 (0.182–2.266) | 0.492 | ||
| Neurological Severity | ||||
| Proximal muscle strength | 0.798 (0.478–1.330) | 0.386 | ||
| Distal muscle strength | 0.978 (0.622–1.537) | 0.923 | ||
| Stenosis of artery | ||||
| Intracranial | 1.375 (0.521–3.631) | 0.520 | ||
| Extracranial | 1.383 (0.424–4.514) | 0.591 | ||
| Distribution of ischemic lesion | ||||
| Anterior circulation | 4.200 (1.307–13.497) | 0.016 | 4.540 (1.257–16.397) | 0.021 |
| Cortex | 3.026 (0.932–9.829) | 0.065 | 4.885 (0.893–26.723) | 0.067 |
| Laboratory findings | ||||
| White blood cell (103/µl) | 1.082 (0.894–1.309) | 0.419 | ||
| Hemoglobin (1003/µl) | 1.004 (0.777–1.296) | 0.978 | ||
| Platelet (103/µl) | 1.001 (0.994–1.008) | 0.771 | ||
| ESR (mm/hr) | 1.015 (0.976–1.056) | 0.451 | ||
| hs-CRP (mg/L) | 0.989 (0.944–1.035) | 0.630 | ||
| Total cholesterol (mg/dl) | 1.002 (0.987–1.016) | 0.830 | ||
| Triglycerides (mg/dl) | 1.000 (0.995–1.005) | 0.947 | ||
| HDL (mg/dl) | 1.023 (0.978–1.071) | 0.325 | ||
| LDL (mg/dl) | 0.998 (0.984–1.012) | 0.774 | ||
| HbA1c (%) | 1.036 (0.748–1.435) | 0.830 | ||
OR odds ratio, CI confidence interval, ESR erythrocyte sedimentation rate, hs-CRP high sensitivity C-reactive protein, HDL high density lipoprotein, LDL low density lipoprotein, HbA1c hemoglobin A1c.
aAdjusted for age, smoking, affected limb edema, anterior circulation, and cortex.
The original Article has been corrected.
Contributor Information
Hwan‑Jeong Jeong, Email: jayjeong@jbnu.ac.kr.
Byoung‑Soo Shin, Email: sbsoo@jbnu.ac.kr.